CTI BioPharma soars on deal news, while Upstart and Rivian climb after earnings

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 97%

Österreich Nachrichten Nachrichten

Österreich Neuesten Nachrichten,Österreich Schlagzeilen

CTI Biotech, Upstart, RingCentral, Twilio and H&R Block were among some of Wednesday's biggest moving stocks in premarket trading.

CTI BioPharma Corp. CTIC stock soared 83% in premarket trading after Swedish Orphan Biovitrum AB SE:SOBI said it had entered into an agreement to acquire the biotech in a deal valued at $1.7 billion. The offer represents a premium of 88.8% over CTI’s... Here are some of the biggest stock moves in premarket action on Wednesday:CTI BioPharma Corp.

Shares of IAC Inc. IAC climbed nearly 9% after the internet and media holding company posted sales of $1.08 billion, down 18% from a year ago but eclipsing analyst estimates of $1.06 billion. Toast Inc. TOST shares rose 4% after the restaurant-industry software provider reported a beat-and-raise quarter.

Shares of H&R Block Inc. HRB fell 8% after the tax-preparation company slashed its outlook for the full fiscal year, blaming a tax season that didn’t pan out according to expectations.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

 /  🏆 3. in AT
 

Vielen Dank für Ihren Kommentar.Ihr Kommentar wird nach Prüfung veröffentlicht.

Österreich Neuesten Nachrichten, Österreich Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Upstart stock soars as earnings outlook positively surprisesShares of Upstart were rocketing 27% in after-hours trading Tuesday after the financial-services company delivered an upbeat outlook for the current period.
Herkunft: MarketWatch - 🏆 3. / 97 Weiterlesen »

Baxter to divest biopharma business for $4.25 billionBaxter International Inc said on Monday a private-equity group, which includes Warburg Pincus and Advent International, has agreed to buy its biopharma solutions unit for $4.25 billion.
Herkunft: Reuters - 🏆 2. / 97 Weiterlesen »